Welcome to our dedicated page for Atmofizer Techno news (Ticker: ATMFF), a resource for investors and traders seeking the latest updates and insights on Atmofizer Techno stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Atmofizer Techno's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Atmofizer Techno's position in the market.
Atmofizer Technologies Inc. announced that independent testing of its Atmofizer ONE technology revealed a 99.99% effectiveness against targeted viruses and bacteria without filters. The test demonstrated over a 4-log reduction of microorganisms, including gram-positive and gram-negative bacteria and enveloped viruses. The FDA has not evaluated the technology, which operates under a policy for air purifiers amid the COVID-19 pandemic. Atmofizer aims to enhance air quality while reducing customer costs and environmental impact through its patented agglomeration technology.
Atmofizer Technologies announced that the USPTO has issued a Notice of Allowance for its patent application related to air purification technology, titled "Ultra-Fine Particle Aggregation, Neutralization and Filtration." This patent allows Atmofizer to apply its technology in the HVAC industry, enhancing air quality and reducing energy costs. The company aims to license this technology to manufacturers and suppliers. The U.S. HVAC systems market is projected to grow, driven by energy efficiency demands and government incentives.
Atmofizer Technologies, reported a positive corporate update on May 31, 2022, focusing on its clean air technology advancements. The CEO highlighted the importance of clean air post-COVID-19 and the company's readiness to meet new regulations. Atmofizer has secured a distribution partnership with Safeware Inc., enhancing its presence in the HVAC industry. Despite supply chain challenges, the company maintains a strong cash position and continues to develop technology aimed at improving air quality and energy efficiency.
Atmofizer Technologies Inc. announced its financial results for Q1 2022, reporting revenue of $210,000 and a gross profit of $60,293 (29%) compared to zero revenue in Q1 2021. Expenses rose to $6.5 million from $2.3 million in the previous year, primarily due to $4.6 million in share-based payments. The adjusted EBITDA loss was $1.6 million, worsening from a $0.7 million loss last year. Key developments included a new lease-finance program for customers and a distribution agreement with Safeware. Atmofizer holds U.S. Patent No. 11,291,939 for its air purification technology.
Atmofizer Technologies Inc. has signed a distribution agreement with Safeware Inc., a leading provider of safety equipment to U.S. governments and educational institutions. Effective Q3 2022, Atmofizer's air purification products will be included in Safeware's inventory, with revenue expected by Q4 2022. This partnership aims to enhance market access for Atmofizer's technology, focusing on air quality and operational cost efficiency. CEO Olivier Centner and other executives express confidence that Safeware's established presence will help deliver cleaner air solutions to public sector clients.
Atmofizer Technologies Inc. has announced the launch of a new lease-finance program through its leasing subsidiary, allowing customers to acquire air purifiers for less than $1 per day. Customers can begin with a down payment ranging from $0 to $99, followed by a monthly fee of $29.99 for a 36-month term. This initiative aims to enhance accessibility to Atmofizer's technology, particularly for sectors like hospitality and education that have been financially impacted by the pandemic. The company claims its air purifiers significantly reduce airborne viruses, enhancing air safety without ongoing filter costs.
Atmofizer Technologies Inc. announced an interview featuring Chief Commercial Officer Whit Pepper on May 12, 2022, discussing opportunities in the air tech industry. The conversation highlighted the company's proprietary nanoparticle reduction systems that efficiently address hazardous airborne particles, potentially lowering filtration costs and benefiting the environment. Pepper emphasized a strategic shift in air purification focus beyond traditional filters, believing the market will continue to grow post-pandemic. Atmofizer aims to disrupt the air treatment industry with innovative solutions for consumers and businesses.
Atmofizer Technologies Inc. (OTCQB: ATMFF) reported promising results from its Toronto lab, demonstrating an 81.7% reduction of airborne ultra-fine particles under one micron without an air filter. The technology also doubled particles above 2.5 microns, aiding easier filtration. Adding staff to enhance mobile and HVAC testing, Atmofizer aims to improve air quality and potentially disrupt the air treatment industry. The company's technology neutralized a COVID-19 surrogate by 99.99%. With patent-protected solutions, Atmofizer is focused on enhancing air purification efficiency.
Atmofizer Technologies Inc. (CSE: ATMO; OTCQB: ATMFF) has received a significant patent from the USPTO for its air and water purification technology, titled "Ultra-Fine Particle Aggregation, Neutralization and Filtration" (US Patent Application No. 17/471,610). This patent enhances the company's intellectual property protection in the U.S., validating its innovative approach to air purification amid growing concerns about indoor air quality. CEO Olivier Centner emphasized the importance of this patent in advancing their unique technology and securing a foothold in the market.
Atmofizer Technologies Inc. (CSE: ATMO; OTCQB: ATMFF) has announced significant advancements with its agglomeration technology, which effectively reduces ultrafine nanoparticle counts by 44% at a rate of 1.4 liters per minute. This patented method enhances air quality by allowing for safer neutralization of harmful particles. Additionally, Atmofizer has opened a new R&D lab in Toronto aimed at innovating HVAC systems and further testing their technology in practical settings. This initiative could lead to new partnerships and markets if successful.